# AeroVironment Inc: financial statements, quarterly

AVAV · Nasdaq · CIK 1368622 · [Industrials](/sectors/industrials.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/avav.md) · [Financials](/companies/avav/financials.md) · [Filings](/companies/avav/filings.md) · [Insiders](/companies/avav/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/avav/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-10-28) | Q3 FY2024 (2024-01-27) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-27) | Q2 FY2025 (2024-10-26) | Q3 FY2025 (2025-01-25) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-08-02) | Q2 FY2026 (2025-11-01) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [181](/filings/0001558370-24-016018.md) | [187](/filings/0001558370-25-002198.md) | [197 d](/filings/0001104659-26-078906.md) | [189](/filings/0001558370-25-011973.md) | [188](/filings/0001104659-25-119775.md) | [168](/filings/0001104659-26-076141.md) | [275 d](/filings/0001104659-26-078906.md) | [455](/filings/0001104659-26-106423.md) | [473](/filings/0001104659-25-119775.md) | [408](/filings/0001104659-26-076141.md) | [642 d](/filings/0001104659-26-078906.md) | [480](/filings/0001104659-26-106423.md) |
| Cost of revenue | $m | [105](/filings/0001558370-24-016018.md) | [119](/filings/0001558370-25-002198.md) | [121 d](/filings/0001104659-26-078906.md) | [108](/filings/0001558370-25-011973.md) | [115](/filings/0001104659-25-119775.md) | [104](/filings/0001104659-26-076141.md) | [175 d](/filings/0001104659-26-078906.md) | [360](/filings/0001104659-26-106423.md) | [368](/filings/0001104659-25-119775.md) | [309](/filings/0001104659-26-076141.md) | [439 d](/filings/0001104659-26-078906.md) | [356](/filings/0001104659-26-106423.md) |
| Gross profit | $m | [75.4](/filings/0001558370-24-016018.md) | [67.3](/filings/0001558370-25-002198.md) | [75.6 d](/filings/0001104659-26-078906.md) | [81.5](/filings/0001558370-25-011973.md) | [73.6](/filings/0001104659-25-119775.md) | [63.2](/filings/0001104659-26-076141.md) | [100 d](/filings/0001104659-26-078906.md) | [95.1](/filings/0001104659-26-106423.md) | [104](/filings/0001104659-25-119775.md) | [98.8](/filings/0001104659-26-076141.md) | [203 d](/filings/0001104659-26-078906.md) | [125](/filings/0001104659-26-106423.md) |
| Research and development | $m | [22.0](/filings/0001558370-24-016018.md) | [25.1](/filings/0001558370-25-002198.md) | [35.1 d](/filings/0001104659-26-078906.md) | [24.6](/filings/0001558370-25-011973.md) | [28.7](/filings/0001104659-25-119775.md) | [22.5](/filings/0001104659-26-076141.md) | [24.9 d](/filings/0001104659-26-078906.md) | [33.1](/filings/0001104659-26-106423.md) | [36.0](/filings/0001104659-25-119775.md) | [27.1](/filings/0001104659-26-076141.md) | [31.5 d](/filings/0001104659-26-078906.md) | [24.0](/filings/0001104659-26-106423.md) |
| Selling, general and administrative | $m | [28.1](/filings/0001558370-24-016018.md) | [27.8](/filings/0001558370-25-002198.md) | [34.6 d](/filings/0001104659-26-078906.md) | [33.8](/filings/0001558370-25-011973.md) | [37.9](/filings/0001104659-25-119775.md) | [43.8](/filings/0001104659-26-076141.md) | [43.3 d](/filings/0001104659-26-078906.md) | [131](/filings/0001104659-26-106423.md) | [98.3](/filings/0001104659-25-119775.md) | [99.4](/filings/0001104659-26-076141.md) | [114 d](/filings/0001104659-26-078906.md) | [112](/filings/0001104659-26-106423.md) |
| Operating income | $m | [25.2](/filings/0001558370-24-016018.md) | [14.3](/filings/0001558370-25-002198.md) | [5.9 d](/filings/0001104659-26-078906.md) | [23.1](/filings/0001558370-25-011973.md) | [7.0](/filings/0001104659-25-119775.md) | [(3.1)](/filings/0001104659-26-076141.md) | [13.8 d](/filings/0001104659-26-078906.md) | [(69.3)](/filings/0001104659-26-106423.md) | [(30.2)](/filings/0001104659-25-119775.md) | [(268)](/filings/0001104659-26-076141.md) | [56.9 d](/filings/0001104659-26-078906.md) | [(10.9)](/filings/0001104659-26-106423.md) |
| Income tax | $m | [1.1](/filings/0001558370-24-016018.md) | [1.3](/filings/0001558370-25-002198.md) | [(1.8) d](/filings/0001104659-26-078906.md) | [1.5](/filings/0001558370-25-011973.md) | [(0.2)](/filings/0001104659-25-119775.md) | [(0.6)](/filings/0001104659-26-076141.md) | [0.2 d](/filings/0001104659-26-078906.md) | [(15.2)](/filings/0001104659-26-106423.md) | [(2.3)](/filings/0001104659-25-119775.md) | [(21.6)](/filings/0001104659-26-076141.md) | [16.0 d](/filings/0001104659-26-078906.md) | [(0.4)](/filings/0001104659-26-106423.md) |
| Net income | $m | [17.8](/filings/0001558370-24-016018.md) | [13.9](/filings/0001558370-25-002198.md) | [6.0 d](/filings/0001104659-26-078906.md) | [21.2](/filings/0001558370-25-011973.md) | [7.5](/filings/0001104659-25-119775.md) | [(1.8)](/filings/0001104659-26-076141.md) | [16.7 d](/filings/0001104659-26-078906.md) | [(67.4)](/filings/0001104659-26-106423.md) | [(17.1)](/filings/0001104659-25-119775.md) | [(244)](/filings/0001104659-26-076141.md) | [63.2 d](/filings/0001104659-26-078906.md) | [(5.1)](/filings/0001104659-26-106423.md) |
| Diluted EPS | $ per share | [0.66](/filings/0001558370-24-016018.md) | [0.50](/filings/0001558370-25-002198.md) | not reported | [0.75](/filings/0001558370-25-011973.md) | [0.27](/filings/0001104659-25-119775.md) | [(0.06)](/filings/0001104659-26-076141.md) | not reported | [(1.44)](/filings/0001104659-26-106423.md) | [(0.34)](/filings/0001104659-25-119775.md) | [(4.90)](/filings/0001104659-26-076141.md) | not reported | [(0.10)](/filings/0001104659-26-106423.md) |
| Basic EPS | $ per share | [0.66](/filings/0001558370-24-016018.md) | [0.50](/filings/0001558370-25-002198.md) | not reported | [0.76](/filings/0001558370-25-011973.md) | [0.27](/filings/0001104659-25-119775.md) | [(0.06)](/filings/0001104659-26-076141.md) | not reported | [(1.44)](/filings/0001104659-26-106423.md) | [(0.34)](/filings/0001104659-25-119775.md) | [(4.90)](/filings/0001104659-26-076141.md) | not reported | [(0.10)](/filings/0001104659-26-106423.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-10-28) | Q3 FY2024 (2024-01-27) | FY2024 (2024-04-30) | Q1 FY2025 (2024-07-27) | Q2 FY2025 (2024-10-26) | Q3 FY2025 (2025-01-25) | FY2025 (2025-04-30) | Q1 FY2026 (2025-08-02) | Q2 FY2026 (2025-11-01) | Q3 FY2026 (2026-01-31) | FY2026 (2026-04-30) | Q1 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [101](/filings/0001558370-23-019483.md) | [108](/filings/0001558370-24-002395.md) | [73.3](/filings/0001558370-25-008838.md) | [81.2](/filings/0001558370-24-012587.md) | [69.0](/filings/0001558370-24-016018.md) | [47.0](/filings/0001558370-25-002198.md) | [40.9](/filings/0001104659-26-078906.md) | [686](/filings/0001558370-25-011973.md) | [359](/filings/0001104659-25-119775.md) | [290](/filings/0001104659-26-076141.md) | [377](/filings/0001104659-26-106423.md) | [278](/filings/0001104659-26-106423.md) |
| Current assets | $m | [524](/filings/0001558370-23-019483.md) | [501](/filings/0001558370-24-002395.md) | [516](/filings/0001558370-25-008838.md) | [500](/filings/0001558370-24-012587.md) | [515](/filings/0001558370-24-016018.md) | [544](/filings/0001558370-25-002198.md) | [607](/filings/0001104659-26-078906.md) | [1,639](/filings/0001558370-25-011973.md) | [1,666](/filings/0001104659-25-119775.md) | [1,704](/filings/0001104659-26-076141.md) | [1,890](/filings/0001104659-26-106423.md) | [1,882](/filings/0001104659-26-106423.md) |
| Total assets | $m | [1,007](/filings/0001558370-23-019483.md) | [980](/filings/0001558370-24-002395.md) | [1,016](/filings/0001558370-25-008838.md) | [999](/filings/0001558370-24-012587.md) | [1,019](/filings/0001558370-24-016018.md) | [1,048](/filings/0001558370-25-002198.md) | [1,121](/filings/0001104659-26-078906.md) | [5,624](/filings/0001558370-25-011973.md) | [5,638](/filings/0001104659-25-119775.md) | [5,364](/filings/0001104659-26-076141.md) | [5,717](/filings/0001104659-26-106423.md) | [5,731](/filings/0001104659-26-106423.md) |
| Current liabilities | $m | [109](/filings/0001558370-23-019483.md) | [108](/filings/0001558370-24-002395.md) | [145](/filings/0001558370-25-008838.md) | [117](/filings/0001558370-24-012587.md) | [112](/filings/0001558370-24-016018.md) | [129](/filings/0001558370-25-002198.md) | [172](/filings/0001104659-26-078906.md) | [275](/filings/0001558370-25-011973.md) | [328](/filings/0001104659-25-119775.md) | [309](/filings/0001104659-26-076141.md) | [439](/filings/0001104659-26-106423.md) | [442](/filings/0001104659-26-106423.md) |
| Long-term debt | $m | [73.7](/filings/0001558370-23-019483.md) | [31.3](/filings/0001558370-24-002395.md) | [17.1](/filings/0001558370-25-008838.md) | [6.8](/filings/0001558370-24-012587.md) | [15.0](/filings/0001558370-24-016018.md) | [25.0](/filings/0001558370-25-002198.md) | [30.0](/filings/0001104659-26-078906.md) | [726](/filings/0001558370-25-011973.md) | [727](/filings/0001104659-25-119775.md) | [728](/filings/0001104659-26-076141.md) | [729](/filings/0001104659-26-106423.md) | [730](/filings/0001104659-26-106423.md) |
| Current portion of debt | $m | [5.0](/filings/0001558370-23-019483.md) | [7.5](/filings/0001558370-24-002395.md) | [10.0](/filings/0001558370-25-008838.md) | [10.0](/filings/0001558370-24-012587.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [794](/filings/0001558370-25-002198.md) | [813](/filings/0001558370-25-002198.md) | [823](/filings/0001104659-26-078906.md) | [846](/filings/0001104659-25-119775.md) | [858](/filings/0001104659-26-076141.md) | [861](/filings/0001104659-26-076141.md) | [887](/filings/0001104659-26-106423.md) | [4,427](/filings/0001104659-26-106423.md) | [4,418](/filings/0001104659-26-076141.md) | [4,185](/filings/0001104659-26-076141.md) | [4,400](/filings/0001104659-26-106423.md) | [4,396](/filings/0001104659-26-106423.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-10-28) | Q3 FY2024 (2024-01-27) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-27) | Q2 FY2025 (2024-10-26) | Q3 FY2025 (2025-01-25) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-08-02) | Q2 FY2026 (2025-11-01) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(8.5) d](/filings/0001558370-24-016018.md) | [52.6 d](/filings/0001558370-25-002198.md) | [(11.7) d](/filings/0001104659-26-078906.md) | [28.4](/filings/0001558370-25-011973.md) | [(3.6) d](/filings/0001104659-25-119775.md) | [(25.8) d](/filings/0001104659-26-076141.md) | [(0.3) d](/filings/0001104659-26-078906.md) | [(124)](/filings/0001104659-26-106423.md) | [(45.1) d](/filings/0001104659-25-119775.md) | [(5.1) d](/filings/0001104659-26-076141.md) | [95.5 d](/filings/0001104659-26-078906.md) | [13.5](/filings/0001104659-26-106423.md) |
| Capital expenditure | $m | [6.5 d](/filings/0001558370-24-016018.md) | [3.8 d](/filings/0001558370-25-002198.md) | [9.1 d](/filings/0001104659-26-078906.md) | [5.4](/filings/0001558370-25-011973.md) | [5.0 d](/filings/0001104659-25-119775.md) | [3.8 d](/filings/0001104659-26-076141.md) | [5.3 d](/filings/0001104659-26-078906.md) | [22.7](/filings/0001104659-26-106423.md) | [10.8 d](/filings/0001104659-25-119775.md) | [12.6 d](/filings/0001104659-26-076141.md) | [16.4 d](/filings/0001104659-26-078906.md) | [44.0](/filings/0001104659-26-106423.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2022-10-29) | Q3 FY2023 (2023-01-28) | Q1 FY2024 (2023-07-29) | Q2 FY2024 (2023-10-28) | Q3 FY2024 (2024-01-27) | Q1 FY2025 (2024-07-27) | Q2 FY2025 (2024-10-26) | Q3 FY2025 (2025-01-25) | Q1 FY2026 (2025-08-02) | Q2 FY2026 (2025-11-01) | Q3 FY2026 (2026-01-31) | Q1 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.9](/filings/0001558370-23-019483.md) | [25.0](/filings/0001558370-24-002395.md) | [26.2](/filings/0001558370-24-012587.md) | [27.0](/filings/0001558370-24-016018.md) | [28.0](/filings/0001558370-25-002198.md) | [28.3](/filings/0001558370-25-011973.md) | [28.1](/filings/0001104659-25-119775.md) | [28.0](/filings/0001104659-26-076141.md) | [46.9](/filings/0001104659-26-106423.md) | [49.7](/filings/0001104659-25-119775.md) | [49.7](/filings/0001104659-26-076141.md) | [49.8](/filings/0001104659-26-106423.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 50,820,702 at 2026-09-03, from the cover of the [10-Q filed 2026-09-10](/filings/0001104659-26-106423.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.